LSTM Home > LSTM Research > LSTM Online Archive

Patient costs during tuberculosis treatment in Bangladesh and Tanzania: the potential of shorter regimens

Gospodarevskaya, Elena, Tulloch, Olivia, Bunga, C., Ferdous, S., Jonas, A., Islam, S., Rahman, M., Hussain, M. A., Haque, M. N., Egwaga, S., Gardiner, E., PrayGod, G., Islam, M. A., Mann, Gillian, Wells, W. A. and Squire, Bertie ORCID: https://orcid.org/0000-0001-7173-9038 (2014) 'Patient costs during tuberculosis treatment in Bangladesh and Tanzania: the potential of shorter regimens'. International Journal of Tuberculosis and Lung Disease, Vol 18, Issue 7, pp. 810-817.

Full text not available from this repository.

Abstract

To estimate the costs incurred by patients during the intensive and continuation phases of the current 6-month tuberculosis (TB) regimen in Bangladesh and Tanzania, and thus identify potential benefits to patients of a shorter, 4-month treatment regimen.

The validated Stop TB patient cost questionnaire was adapted and used in interviews with 190 patients in the continuation phase of treatment with current regimens.

In both countries, overall patient costs were lower during 2 months of the continuation phase (US$74 in Tanzania and US$56 in Bangladesh) than during the 2 months of the intensive phase of treatment (US$150 and US$111, respectively). However, continuation phase patient costs still represented 89% and 77% of the 2-month average national income in the respective countries. Direct travel costs in some settings were kept low by local delivery system features such as community treatment observation. Lost productivity and costs for supplementary foods remained significant.

Although it is not a straightforward exercise to determine the exact magnitude of likely savings, a shorter regimen would reduce out-of-pocket expenses incurred by patients in the most recent 2 months of the continuation phase and allow an earlier return to productive activities.

Item Type: Article
Subjects: W General Medicine. Health Professions > Health Services. Patients and Patient Advocacy > W 84 Health services. Delivery of health care
WA Public Health > WA 30 Socioeconomic factors in public health (General)
WA Public Health > Health Problems of Special Population Groups > WA 395 Health in developing countries
WF Respiratory System > Tuberculosis > WF 200 Tuberculosis (General)
Faculty: Department: Clinical Sciences & International Health > Clinical Sciences Department
Clinical Sciences & International Health > International Public Health Department
Digital Object Identifer (DOI): https://doi.org/10.5588/ijtld.13.0391
Depositing User: Lynn Roberts-Maloney
Date Deposited: 05 Jun 2014 12:47
Last Modified: 07 Jun 2022 11:09
URI: https://archive.lstmed.ac.uk/id/eprint/3755

Statistics

View details

Actions (login required)

Edit Item Edit Item